Pyrilamine
Pyrilamine is a first-generation antihistamine used to relieve symptoms of allergies, hay fever, and the common cold. It works by blocking histamine H1 receptors, reducing allergic reactions such as sneezing, itching, watery eyes, and runny nose. Due to its sedative properties, it is sometimes included in over-the-counter sleep aids and combination products.
Pyrilamine is an antihistamine that treats allergy symptoms like sneezing and itching by blocking histamine receptors, but causes drowsiness.
Key facts at a glance
- ATC
- atc-d04
- RxNorm
- 1113
- Generic
- Pyrilamine
- Class
- atc-d04
- Brands
- Pamprin Multi-Symptom, Premsyn PMS, Ninjacof, Ninjacof A, Vanacof AC, Pediaclear, Poly Hist PD
- Availability
- otc
- Pregnancy
- B
- Lactation
- caution
- Half-life (h)
- 2.5
- Onset (min)
- 30
- Duration (h)
- 6
- Routes
- oral, topical, nasal
- Forms
- tablet, capsule, syrup, liquid, cream, nasal spray
- Regions
- United States, Canada, United Kingdom, Australia, Europe, India
- Monitoring
- sedation, drowsiness, dry mouth, blurred vision
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Dosage and administration
- Usual dose
- 25-50mg every 4-6 hours
- Maximum
- consult physician
- Frequency
- every 4-6 hours as needed
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
- Usual dose
- 12.5-25mg every 4-6 hours
- Maximum
- consult physician
- Frequency
- every 4-6 hours as needed
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
- Usual dose
- 25mg every 4-6 hours
- Maximum
- consult physician
- Frequency
- every 4-6 hours as needed
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
Overdose information
Special Populations
8 groupspregnancy
first trimesteravoid if possible
avoid use during pregnancy unless benefits outweigh risks; use only if clearly necessary
regular prenatal monitoring
Use with caution and monitor for adverse effects.
pregnancy
third trimesteravoid close to delivery
avoid use near term; may affect fetal heart rate and cause neonatal respiratory depression
fetal monitoring in third trimester
Use with caution and monitor for adverse effects.
lactation
breastfeedingdiscontinue breastfeeding or avoid drug
pyrnilamine is excreted in breast milk; avoid use while breastfeeding
monitor infant for excessive drowsiness
Use of this medication in this population requires careful consideration of risks and benefits.
geriatric
elderlyreduce dose and increase dosing interval
use lower initial dose; increased sensitivity to anticholinergic effects; monitor for dizziness and sedation
monitor for falls, confusion, and anticholinergic effects
Use with caution and monitor for adverse effects.
pediatric_age
infants and toddlersdo not use
do not use in children under 2 years of age; risk of severe CNS depression
not applicable
Use of this medication in this population requires careful consideration of risks and benefits.
pediatric_age
children 2 to 12use weight-based dosing
use with caution; may cause paradoxical excitement; avoid in children with asthma
monitor for behavioral changes and respiratory depression
Use with caution and monitor for adverse effects.
renal_impairment
severereduce dose by 50%
use with caution; drug is partially excreted renally; monitor renal function
monitor renal function and adjust dose accordingly
Use with caution and monitor for adverse effects.
hepatic_impairment
severereduce dose by 50%
use with caution; drug is metabolized in liver; monitor liver function
monitor liver function tests
Use with caution and monitor for adverse effects.
Statistics and clinical data
First FDA approval
Historical prescribing information for pyrilamine
Drug class
Antihistamine classification
Common uses
Therapeutic applications
Mechanism of action
Pharmacological mechanism
Pyrilamine is used to treat allergic conditions including seasonal allergies, hay fever, allergic rhinitis, urticaria (hives), and pruritus (itching). It is also found in some cold medications and sleep aids for its antihistamine and sedative effects.
Pyrilamine is a competitive antagonist at H1 histamine receptors. By blocking histamine from binding to these receptors, it prevents allergic inflammatory responses and reduces symptoms such as sneezing, itching, nasal discharge, and watery eyes.
As a first-generation antihistamine, pyrilamine commonly causes drowsiness and should be used with caution when operating machinery or driving. It may also cause dry mouth, blurred vision, and urinary retention. Alcohol and other sedatives can enhance drowsiness. This medication is generally not recommended for use in children without medical supervision.
Contraindications
Conditions and patient states where this medication should be avoided or used with caution.
Do not use (1)
Known allergy to this medication or its components
Use caution (1)
Consult healthcare provider for benefits vs risks assessment
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy